Laboratoires Euromedis Société anonyme (FRA:61R)
Germany flag Germany · Delayed Price · Currency is EUR
4.040
-0.200 (-4.72%)
At close: Jan 30, 2026

FRA:61R Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
---5.932.2622.66
Depreciation & Amortization
--1.1214.44
Loss (Gain) From Sale of Assets
--0.023.180.02
Asset Writedown & Restructuring Costs
--0.521.130.72
Loss (Gain) on Equity Investments
---0.02-0.020.12
Other Operating Activities
---0.65-3.971.09
Change in Other Net Operating Assets
--3.8915.66-15.54
Operating Cash Flow
---1.0519.2513.5
Operating Cash Flow Growth
---42.55%-
Capital Expenditures
---1.03-1.84-0.66
Sale of Property, Plant & Equipment
---0.40.01
Cash Acquisitions
---0.06-0.13-
Investment in Securities
--0.020.430.06
Other Investing Activities
----0-
Investing Cash Flow
---1.07-1.13-0.59
Long-Term Debt Issued
----20
Total Debt Issued
----20
Short-Term Debt Repaid
---0-0.01-0.02
Long-Term Debt Repaid
---2.16-1.29-10.63
Total Debt Repaid
---2.16-1.3-10.65
Net Debt Issued (Repaid)
---2.16-1.39.35
Issuance of Common Stock
---0.02-
Repurchase of Common Stock
---0.28--0.09
Other Financing Activities
--0.030.030.03
Financing Cash Flow
---2.41-1.259.29
Miscellaneous Cash Flow Adjustments
---0-
Net Cash Flow
---4.5216.8722.2
Free Cash Flow
---2.0817.4112.84
Free Cash Flow Growth
---35.55%-
Free Cash Flow Margin
---3.84%15.56%6.64%
Free Cash Flow Per Share
---0.694.863.58
Levered Free Cash Flow
--0.7317.277.11
Unlevered Free Cash Flow
--0.9517.497.4
Change in Working Capital
--3.8915.66-15.54
Source: S&P Global Market Intelligence. Standard template. Financial Sources.